Anther Keung

1.2k total citations
24 papers, 948 citations indexed

About

Anther Keung is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Anther Keung has authored 24 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Oncology. Recurrent topics in Anther Keung's work include HIV/AIDS drug development and treatment (8 papers), Pharmacological Effects and Toxicity Studies (6 papers) and HIV Research and Treatment (5 papers). Anther Keung is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), Pharmacological Effects and Toxicity Studies (6 papers) and HIV Research and Treatment (5 papers). Anther Keung collaborates with scholars based in United States, Germany and France. Anther Keung's co-authors include Hilde Rosing, Herbert M. Pinedo, Jos H. Beijnen, Manon Huizing, Scott J. Weir, Mark G. Eller, I. Mandjes, Anne-Charlotte Dubbelman, W.W. ten Bokkel Huinink and Lip Yong Chung and has published in prestigious journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Anther Keung

24 papers receiving 879 citations

Peers

Anther Keung

ONCOL

EPIDE

PHARM

Marie‐Claude Gagnieu France

Dominique Challine France

Anne Hulin France

Li‐Tain Yeh United States

Sarah Allegra Italy

S. Aubrey Stoch United States

J. H. Beijnen Netherlands

Melinda J. Reese United States

Rajeev Menon United States

J. H. Beijnen Netherlands

Marie‐Claude Gagnieu France

Anther Keung

145 ×0.4

ONCOL

278 ×0.9

273 ×1.4

EPIDE

169 ×0.9

71 ×0.5

PHARM

Citations per year, relative to Anther Keung Anther Keung (= 1×) peers Marie‐Claude Gagnieu

Countries citing papers authored by Anther Keung

Since Specialization

Citations

This map shows the geographic impact of Anther Keung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anther Keung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anther Keung more than expected).

Fields of papers citing papers by Anther Keung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anther Keung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anther Keung. The network helps show where Anther Keung may publish in the future.

Co-authorship network of co-authors of Anther Keung

This figure shows the co-authorship network connecting the top 25 collaborators of Anther Keung. A scholar is included among the top collaborators of Anther Keung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anther Keung. Anther Keung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crison, John R., et al.. (2012). Biowaiver Approach for Biopharmaceutics Classification System Class 3 Compound Metformin Hydrochloride Using In Silico Modeling. Journal of Pharmaceutical Sciences. 101(5). 1773–1782. 35 indexed citations

Kasserra, Claudia, Angela Sansone‐Parsons, Anther Keung, et al.. (2010). Renal Insufficiency Has No Effect on the Pharmacokinetics of Vicriviroc in a Ritonavir-Containing Regimen. Clinical Pharmacokinetics. 49(6). 397–406. 5 indexed citations

Crawford, Keith W., Chonghua Li, Anther Keung, et al.. (2010). Pharmacokinetic/Pharmacodynamic Modeling of the Antiretroviral Activity of the CCR5 Antagonist Vicriviroc in Treatment Experienced HIV-Infected Subjects (ACTG Protocol 5211). JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(5). 598–605. 9 indexed citations

Fätkenheuer, Gerd, Christian Hoffmann, Jihad Slim, et al.. (2009). Short-Term Administration of the CCR5 Antagonist Vicriviroc to Patients With HIV and HCV Coinfection Is Safe and Tolerable. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(1). 78–85. 5 indexed citations

Schürmann, Dirk, Gerd Fätkenheuer, Jacques Reynes, et al.. (2007). Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults. AIDS. 21(10). 1293–1299. 66 indexed citations

Li, Cheng, Anther Keung, Richard A. Morrison, & Ronald E. White. (2005). Vicriviroc, A Novel CCR5 Inhibitor, is NOT A p-glycoprotein Substrate In Vitro. Retrovirology. 2(S1). 3 indexed citations

Banfield, Christopher, Jerry Herron, Anther Keung, Desmond Padhi, & Melton B. Affrime. (2002). Desloratadine Has No Clinically Relevant Electrocardiographic or Pharmacodynamic Interactions with Ketoconazole. Clinical Pharmacokinetics. 41(Supplement 1). 37–44. 42 indexed citations

Keung, Anther, Teddy Kosoglou, Paul Statkevich, et al.. (2001). Ezetimibe does not affect the pharmacokinetics of oral contraceptives. Clinical Pharmacology & Therapeutics. 69(2). 55. 27 indexed citations

Keung, Anther, et al.. (1999). Pharmacokinetics of dolasetron with coadministration of cimetidine or rifampin in healthy subjects. Cancer Chemotherapy and Pharmacology. 43(2). 126–132. 12 indexed citations

10.

Keung, Anther, et al.. (1999). Single and multiple dose pharmacokinetics of rifapentine in man: part II.. PubMed. 3(5). 437–44. 41 indexed citations

11.

Keung, Anther, Robert C. Owens, Mark G. Eller, et al.. (1999). Pharmacokinetics of Rifapentine in Subjects Seropositive for the Human Immunodeficiency Virus: a Phase I Study. Antimicrobial Agents and Chemotherapy. 43(5). 1230–1233. 25 indexed citations

12.

Keung, Anther, et al.. (1999). Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: part I.. PubMed. 3(5). 426–36. 29 indexed citations

13.

Keung, Anther, Mark G. Eller, & Scott J. Weir. (1998). Pharmacokinetics of Rifapentine in Patients with Varying Degrees of Hepatic Dysfunction. The Journal of Clinical Pharmacology. 38(6). 517–524. 14 indexed citations

14.

Keung, Anther, Mark G. Eller, & Scott J. Weir. (1998). Single-dose Pharmacokinetics of Rifapentine in Elderly Men. Pharmaceutical Research. 15(8). 1286–1291. 18 indexed citations

15.

Keung, Anther, et al.. (1998). Single-Dose Pharmacokinetics of Rifapentine in Women. Journal of Pharmacokinetics and Biopharmaceutics. 26(1). 75–85. 11 indexed citations

16.

Keung, Anther, et al.. (1998). The effect of food on the bioavailability of dolasetron mesylate tablets. Biopharmaceutics & Drug Disposition. 19(1). 17–19. 5 indexed citations

17.

Lerman, Jerrold, Nancy Sikich, Robert M. Gow, et al.. (1996). Pharmacokinetics of the active metabolite (MDL 74,156) of dolasetron mesylate after oral or intravenous administration to anesthetized children*. Clinical Pharmacology & Therapeutics. 60(5). 485–492. 10 indexed citations

18.

Huizing, Manon, et al.. (1995). High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine. Journal of Chromatography B Biomedical Sciences and Applications. 664(2). 373–382. 102 indexed citations

19.

Huizing, Manon, Anther Keung, Hilde Rosing, et al.. (1993). Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.. Journal of Clinical Oncology. 11(11). 2127–2135. 263 indexed citations

20.

Wick, Peter, Anther Keung, Jean Bowler, & Richard C. Deth. (1987). Alpha-1 adrenergic coupling events induced by full and partial agonists in rabbit aorta.. Journal of Pharmacology and Experimental Therapeutics. 241(2). 458–464. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact